Dr Dennis Carl Jerome, MD | |
3801 Katella Ave, Suite 201, Los Alamitos, CA 90720-3338 | |
(714) 892-7735 | |
(562) 594-8832 |
Full Name | Dr Dennis Carl Jerome |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 3801 Katella Ave, Los Alamitos, California |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1720090301 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207K00000X | Allergy & Immunology | C34461 (California) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Dennis Carl Jerome, MD 3801 Katella Ave, Suite 201, Los Alamitos, CA 90720-3338 Ph: (714) 892-7735 | Dr Dennis Carl Jerome, MD 3801 Katella Ave, Suite 201, Los Alamitos, CA 90720-3338 Ph: (714) 892-7735 |
News Archive
Havas Health today announced the acquisition of Just:: Health Communications, a leading London agency known for its innovative work and for providing services to global clients in public relations, medical communications, public affairs and digital communications. Just:: was founded in 2006 by Jennie Talman and Emma Crozier.
Researchers at Binghamton University, State University of New York, have identified three key regulators required for the formation and development of biofilms. The discovery could lead to new ways of treating chronic infections.
Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd. today announced four-year follow-up results from a Phase 3 randomized, open-label, dose-optimization study of SPRYCEL® (dasatinib) in chronic-phase chronic myeloid leukemia (CML-CP) patients resistant or intolerant to Gleevec®* (imatinib mesylate). At four years, for all patients administered SPRYCEL 100 mg once daily, overall survival was 82% (95% CI: 76%-88%) and progression-free survival was 66% (95% CI: 57%-74%).
A more efficient and much faster method to assess high levels of neutralizing antibodies to COVID-19 could point the way to better understanding and treatment of the disease, according to new published findings by scientists from the Hackensack Meridian Center for Discovery and Innovation (CDI) and the University of Michigan (U-M).
A multidisciplinary team of University of North Carolina at Chapel Hill researchers has been awarded a $3.6 million grant to develop computer models that will allow physicians to predict which treatments will work best in children with upper airway problems.
› Verified 1 days ago
Dr. Alexander Eugene Loscialpo, M.D. Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 3801 Katella Ave, 201, Los Alamitos, CA 90720 Phone: 562-594-8831 Fax: 562-594-8832 |